|
Code
|
Display
|
|
7014-4
|
5-Fluorocytosine [Susceptibility] by Gradient strip (E-test) |
|
254-3
|
5-Fluorocytosine [Susceptibility] by Disk diffusion (KB) |
|
253-5
|
5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
252-7
|
5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18855-7
|
5-Fluorocytosine [Susceptibility] |
|
255-0
|
5-Fluorocytosine [Susceptibility] by Serum bactericidal titer |
|
30287-7
|
Abacavir [Susceptibility] by Genotype method |
|
30273-7
|
Abacavir [Susceptibility] by Phenotype method |
|
30303-2
|
Abacavir [Susceptibility] |
|
41660-2
|
ABT492 [Susceptibility] by Gradient strip (E-test) |
|
41659-4
|
ABT492 [Susceptibility] by Disk diffusion (KB) |
|
41658-6
|
ABT492 [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41726-1
|
ABT492 [Susceptibility] |
|
1-8
|
Acyclovir [Susceptibility] |
|
16320-4
|
Acyclovir [Susceptibility] by Serum bactericidal titer |
|
30288-5
|
Adefovir [Susceptibility] by Genotype method |
|
30274-5
|
Adefovir [Susceptibility] by Phenotype method |
|
30304-0
|
Adefovir [Susceptibility] |
|
4-2
|
Almecillin [Susceptibility] by Disk diffusion (KB) |
|
3-4
|
Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
2-6
|
Almecillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18857-3
|
Almecillin [Susceptibility] |
|
5-9
|
Almecillin [Susceptibility] by Serum bactericidal titer |
|
6-7
|
Amantadine [Susceptibility] |
|
16350-1
|
Amantadine [Susceptibility] by Serum bactericidal titer |
|
7028-4
|
Amdinocillin [Susceptibility] by Gradient strip (E-test) |
|
9-1
|
Amdinocillin [Susceptibility] by Disk diffusion (KB) |
|
8-3
|
Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
7-5
|
Amdinocillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18859-9
|
Amdinocillin [Susceptibility] |
|
10-9
|
Amdinocillin [Susceptibility] by Serum bactericidal titer |
|
60564-2
|
Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
48169-7
|
Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25177-7
|
Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25175-1
|
Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42642-9
|
Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25178-5
|
Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25176-9
|
Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
60565-9
|
Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25179-3
|
Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25174-4
|
Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
6975-7
|
Amikacin [Susceptibility] by Gradient strip (E-test) |
|
13-3
|
Amikacin [Susceptibility] by Disk diffusion (KB) |
|
12-5
|
Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
11-7
|
Amikacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20373-7
|
Amikacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18860-7
|
Amikacin [Susceptibility] |
|
14-1
|
Amikacin [Susceptibility] by Serum bactericidal titer |
|
62256-3
|
Aminoglycoside resistance gene [Presence] by Probe & target amplification method |
|
6976-5
|
Amoxicillin [Susceptibility] by Gradient strip (E-test) |
|
17-4
|
Amoxicillin [Susceptibility] by Disk diffusion (KB) |
|
16-6
|
Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
15-8
|
Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18861-5
|
Amoxicillin [Susceptibility] |
|
18-2
|
Amoxicillin [Susceptibility] by Serum bactericidal titer |
|
6977-3
|
Amoxicillin+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
21-6
|
Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
20-8
|
Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
19-0
|
Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) |
|
25310-4
|
Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria |
|
18862-3
|
Amoxicillin+Clavulanate [Susceptibility] |
|
22-4
|
Amoxicillin+Clavulanate [Susceptibility] by Serum bactericidal titer |
|
55615-9
|
Amoxicillin+Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
55616-7
|
Amoxicillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55614-2
|
Amoxicillin+Sulbactam [Susceptibility] |
|
6978-1
|
Amphotericin B [Susceptibility] by Gradient strip (E-test) |
|
25-7
|
Amphotericin B [Susceptibility] by Disk diffusion (KB) |
|
24-0
|
Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23-2
|
Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC) |
|
18863-1
|
Amphotericin B [Susceptibility] |
|
26-5
|
Amphotericin B [Susceptibility] by Serum bactericidal titer |
|
6979-9
|
Ampicillin [Susceptibility] by Gradient strip (E-test) |
|
29-9
|
Ampicillin [Susceptibility] by Disk diffusion (KB) |
|
28-1
|
Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
27-3
|
Ampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18864-9
|
Ampicillin [Susceptibility] |
|
30-7
|
Ampicillin [Susceptibility] by Serum bactericidal titer |
|
6980-7
|
Ampicillin+Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
33-1
|
Ampicillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
32-3
|
Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
31-5
|
Ampicillin+Sulbactam [Susceptibility] by Minimum lethal concentration (MLC) |
|
20374-5
|
Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria |
|
18865-6
|
Ampicillin+Sulbactam [Susceptibility] |
|
34-9
|
Ampicillin+Sulbactam [Susceptibility] by Serum bactericidal titer |
|
30297-6
|
Amprenavir [Susceptibility] by Genotype method |
|
30296-8
|
Amprenavir [Susceptibility] by Phenotype method |
|
30299-2
|
Amprenavir [Susceptibility] |
|
49623-2
|
Amprenavir or Fosamprenavir [Susceptibility] by Genotype method |
|
55343-8
|
Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
57095-2
|
Anidulafungin [Susceptibility] |
|
48611-8
|
Antibiotic tested [Identifier] against isolate |
|
23659-6
|
Apramycin [Susceptibility] |
|
54173-0
|
Arbekacin [Susceptibility] by Disk diffusion (KB) |
|
53818-1
|
Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32373-3
|
Arbekacin [Susceptibility] |
|
41403-7
|
Atazanavir [Susceptibility] by Genotype method |
|
49668-7
|
Atazanavir [Susceptibility] by Phenotype method |
|
41993-7
|
Atazanavir [Susceptibility] |
|
49618-2
|
Atazanavir+Ritonavir [Susceptibility] by Genotype method |
|
57907-8
|
Atazanavir+Ritonavir [Susceptibility] by Phenotype method |
|
55618-3
|
Atovaquone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55619-1
|
Avilamycin [Susceptibility] by Gradient strip (E-test) |
|
35754-1
|
Avilamycin [Susceptibility] by Disk diffusion (KB) |
|
35755-8
|
Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35756-6
|
Avilamycin [Susceptibility] |
|
16421-0
|
Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
6981-5
|
Azithromycin [Susceptibility] by Gradient strip (E-test) |
|
37-2
|
Azithromycin [Susceptibility] by Disk diffusion (KB) |
|
36-4
|
Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35-6
|
Azithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23612-5
|
Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18866-4
|
Azithromycin [Susceptibility] |
|
38-0
|
Azithromycin [Susceptibility] by Serum bactericidal titer |
|
41661-0
|
Azlocillin [Susceptibility] by Gradient strip (E-test) |
|
41-4
|
Azlocillin [Susceptibility] by Disk diffusion (KB) |
|
40-6
|
Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
39-8
|
Azlocillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18867-2
|
Azlocillin [Susceptibility] |
|
42-2
|
Azlocillin [Susceptibility] by Serum bactericidal titer |
|
6982-3
|
Aztreonam [Susceptibility] by Gradient strip (E-test) |
|
45-5
|
Aztreonam [Susceptibility] by Disk diffusion (KB) |
|
44-8
|
Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
43-0
|
Aztreonam [Susceptibility] by Minimum lethal concentration (MLC) |
|
18868-0
|
Aztreonam [Susceptibility] |
|
46-3
|
Aztreonam [Susceptibility] by Serum bactericidal titer |
|
41664-4
|
Aztreonam+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
41663-6
|
Aztreonam+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41662-8
|
Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41727-9
|
Aztreonam+Clavulanate [Susceptibility] |
|
55620-9
|
Bacampicillin [Susceptibility] by Gradient strip (E-test) |
|
49-7
|
Bacampicillin [Susceptibility] by Disk diffusion (KB) |
|
48-9
|
Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
47-1
|
Bacampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18869-8
|
Bacampicillin [Susceptibility] |
|
50-5
|
Bacampicillin [Susceptibility] by Serum bactericidal titer |
|
6983-1
|
Bacitracin [Susceptibility] by Gradient strip (E-test) |
|
10868-8
|
Bacitracin [Susceptibility] by Disk diffusion (KB) |
|
6827-0
|
Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
18870-6
|
Bacitracin [Susceptibility] |
|
29576-6
|
Bacterial susceptibility panel in Isolate |
|
49589-5
|
Bacterial susceptibility panel in Isolate by Gradient strip (E-test) |
|
50546-1
|
Bacterial susceptibility panel in Isolate by Disk diffusion (KB) |
|
50545-3
|
Bacterial susceptibility panel in Isolate by Minimum inhibitory concentration (MIC) |
|
55621-7
|
Bambermycins [Susceptibility] by Gradient strip (E-test) |
|
35803-6
|
Bambermycins [Susceptibility] by Disk diffusion (KB) |
|
35804-4
|
Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35805-1
|
Bambermycins [Susceptibility] |
|
41667-7
|
Biapenem [Susceptibility] by Gradient strip (E-test) |
|
41666-9
|
Biapenem [Susceptibility] by Disk diffusion (KB) |
|
41665-1
|
Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41728-7
|
Biapenem [Susceptibility] |
|
49617-4
|
bla(KPC) gene [Presence] by Probe & target amplification method |
|
6984-9
|
Beta lactamase.extended spectrum [Susceptibility] |
|
6985-6
|
Beta lactamase.usual [Susceptibility] |
|
55622-5
|
Butirosin [Susceptibility] by Gradient strip (E-test) |
|
53-9
|
Butirosin [Susceptibility] by Disk diffusion (KB) |
|
52-1
|
Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
51-3
|
Butirosin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18871-4
|
Butirosin [Susceptibility] |
|
54-7
|
Butirosin [Susceptibility] by Serum bactericidal titer |
|
25210-6
|
Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25211-4
|
Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
48170-5
|
Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25212-2
|
Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
61355-4
|
Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55623-3
|
Capreomycin [Susceptibility] by Gradient strip (E-test) |
|
57-0
|
Capreomycin [Susceptibility] by Disk diffusion (KB) |
|
56-2
|
Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55-4
|
Capreomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23607-5
|
Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18872-2
|
Capreomycin [Susceptibility] |
|
58-8
|
Capreomycin [Susceptibility] by Serum bactericidal titer |
|
62237-3
|
Carbapenemase [Susceptibility] |
|
41668-5
|
Carbenicillin [Susceptibility] by Gradient strip (E-test) |
|
61-2
|
Carbenicillin [Susceptibility] by Disk diffusion (KB) |
|
60-4
|
Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
59-6
|
Carbenicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18873-0
|
Carbenicillin [Susceptibility] |
|
62-0
|
Carbenicillin [Susceptibility] by Serum bactericidal titer |
|
51694-8
|
Carumonam [Susceptibility] |
|
54185-4
|
Caspofungin [Susceptibility] by Gradient strip (E-test) |
|
54175-5
|
Caspofungin [Susceptibility] by Disk diffusion (KB) |
|
54176-3
|
Caspofungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32378-2
|
Caspofungin [Susceptibility] |
|
55627-4
|
Cefacetrile [Susceptibility] by Gradient strip (E-test) |
|
55626-6
|
Cefacetrile [Susceptibility] by Disk diffusion (KB) |
|
55624-1
|
Cefacetrile [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55625-8
|
Cefacetrile [Susceptibility] |
|
6986-4
|
Cefaclor [Susceptibility] by Gradient strip (E-test) |
|
85-1
|
Cefaclor [Susceptibility] by Disk diffusion (KB) |
|
84-4
|
Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
83-6
|
Cefaclor [Susceptibility] by Minimum lethal concentration (MLC) |
|
18874-8
|
Cefaclor [Susceptibility] |
|
86-9
|
Cefaclor [Susceptibility] by Serum bactericidal titer |
|
55628-2
|
Cefadroxil [Susceptibility] by Gradient strip (E-test) |
|
65-3
|
Cefadroxil [Susceptibility] by Disk diffusion (KB) |
|
64-6
|
Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
63-8
|
Cefadroxil [Susceptibility] by Minimum lethal concentration (MLC) |
|
18875-5
|
Cefadroxil [Susceptibility] |
|
66-1
|
Cefadroxil [Susceptibility] by Serum bactericidal titer |
|
41669-3
|
Cefamandole [Susceptibility] by Gradient strip (E-test) |
|
69-5
|
Cefamandole [Susceptibility] by Disk diffusion (KB) |
|
68-7
|
Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
67-9
|
Cefamandole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18876-3
|
Cefamandole [Susceptibility] |
|
70-3
|
Cefamandole [Susceptibility] by Serum bactericidal titer |
|
55637-3
|
Cefamandole+Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
55636-5
|
Cefamandole+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55634-0
|
Cefamandole+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55635-7
|
Cefamandole+Sulbactam [Susceptibility] |
|
55639-9
|
Cefatrizine [Susceptibility] by Gradient strip (E-test) |
|
73-7
|
Cefatrizine [Susceptibility] by Disk diffusion (KB) |
|
72-9
|
Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
71-1
|
Cefatrizine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18877-1
|
Cefatrizine [Susceptibility] |
|
74-5
|
Cefatrizine [Susceptibility] by Serum bactericidal titer |
|
41670-1
|
Cefazolin [Susceptibility] by Gradient strip (E-test) |
|
77-8
|
Cefazolin [Susceptibility] by Disk diffusion (KB) |
|
76-0
|
Cefazolin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
75-2
|
Cefazolin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18878-9
|
Cefazolin [Susceptibility] |
|
78-6
|
Cefazolin [Susceptibility] by Serum bactericidal titer |
|
35757-4
|
Cefdinir [Susceptibility] by Gradient strip (E-test) |
|
35758-2
|
Cefdinir [Susceptibility] by Disk diffusion (KB) |
|
23637-2
|
Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23636-4
|
Cefdinir [Susceptibility] |
|
35760-8
|
Cefditoren [Susceptibility] by Gradient strip (E-test) |
|
35759-0
|
Cefditoren [Susceptibility] by Disk diffusion (KB) |
|
35761-6
|
Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35762-4
|
Cefditoren [Susceptibility] |
|
6987-2
|
Cefepime [Susceptibility] by Gradient strip (E-test) |
|
8272-7
|
Cefepime [Susceptibility] by Disk diffusion (KB) |
|
6644-9
|
Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
6643-1
|
Cefepime [Susceptibility] by Minimum lethal concentration (MLC) |
|
50631-1
|
Cefepime [Susceptibility] by Method for Slow-growing mycobacteria |
|
18879-7
|
Cefepime [Susceptibility] |
|
8273-5
|
Cefepime [Susceptibility] by Serum bactericidal titer |
|
35763-2
|
Cefepime+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
42350-9
|
Cefepime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
42351-7
|
Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
42353-3
|
Cefepime+Clavulanate [Susceptibility] |
|
31143-1
|
Cefepime.meningitis [Susceptibility] by Gradient strip (E-test) |
|
58412-8
|
Cefepime.meningitis [Susceptibility] by Disk diffusion (KB) |
|
31142-3
|
Cefepime.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55640-7
|
Cefetamet [Susceptibility] by Gradient strip (E-test) |
|
35764-0
|
Cefetamet [Susceptibility] by Disk diffusion (KB) |
|
35765-7
|
Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32377-4
|
Cefetamet [Susceptibility] |
|
35766-5
|
Cefixime [Susceptibility] by Gradient strip (E-test) |
|
81-0
|
Cefixime [Susceptibility] by Disk diffusion (KB) |
|
80-2
|
Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
79-4
|
Cefixime [Susceptibility] by Minimum lethal concentration (MLC) |
|
18880-5
|
Cefixime [Susceptibility] |
|
82-8
|
Cefixime [Susceptibility] by Serum bactericidal titer |
|
55641-5
|
Cefmenoxime [Susceptibility] by Gradient strip (E-test) |
|
54174-8
|
Cefmenoxime [Susceptibility] by Disk diffusion (KB) |
|
54203-5
|
Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32375-8
|
Cefmenoxime [Susceptibility] |
|
25222-1
|
Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
11575-8
|
Cefmetazole [Susceptibility] by Gradient strip (E-test) |
|
89-3
|
Cefmetazole [Susceptibility] by Disk diffusion (KB) |
|
88-5
|
Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
87-7
|
Cefmetazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18881-3
|
Cefmetazole [Susceptibility] |
|
90-1
|
Cefmetazole [Susceptibility] by Serum bactericidal titer |
|
54908-9
|
Cefminox [Susceptibility] |
|
6988-0
|
Cefodizime [Susceptibility] by Gradient strip (E-test) |
|
93-5
|
Cefodizime [Susceptibility] by Disk diffusion (KB) |
|
92-7
|
Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
91-9
|
Cefodizime [Susceptibility] by Minimum lethal concentration (MLC) |
|
18882-1
|
Cefodizime [Susceptibility] |
|
94-3
|
Cefodizime [Susceptibility] by Serum bactericidal titer |
|
55642-3
|
Cefonicid [Susceptibility] by Gradient strip (E-test) |
|
97-6
|
Cefonicid [Susceptibility] by Disk diffusion (KB) |
|
96-8
|
Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
95-0
|
Cefonicid [Susceptibility] by Minimum lethal concentration (MLC) |
|
18883-9
|
Cefonicid [Susceptibility] |
|
98-4
|
Cefonicid [Susceptibility] by Serum bactericidal titer |
|
35767-3
|
Cefoperazone [Susceptibility] by Gradient strip (E-test) |
|
101-6
|
Cefoperazone [Susceptibility] by Disk diffusion (KB) |
|
100-8
|
Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
99-2
|
Cefoperazone [Susceptibility] by Minimum lethal concentration (MLC) |
|
18884-7
|
Cefoperazone [Susceptibility] |
|
102-4
|
Cefoperazone [Susceptibility] by Serum bactericidal titer |
|
35768-1
|
Cefoperazone+Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
54168-0
|
Cefoperazone+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54167-2
|
Cefoperazone+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54166-4
|
Cefoperazone+Sulbactam [Susceptibility] |
|
55643-1
|
Ceforanide [Susceptibility] by Gradient strip (E-test) |
|
105-7
|
Ceforanide [Susceptibility] by Disk diffusion (KB) |
|
104-0
|
Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
103-2
|
Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) |
|
18885-4
|
Ceforanide [Susceptibility] |
|
106-5
|
Ceforanide [Susceptibility] by Serum bactericidal titer |
|
6989-8
|
Cefotaxime [Susceptibility] by Gradient strip (E-test) |
|
109-9
|
Cefotaxime [Susceptibility] by Disk diffusion (KB) |
|
108-1
|
Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
107-3
|
Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) |
|
50632-9
|
Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria |
|
18886-2
|
Cefotaxime [Susceptibility] |
|
110-7
|
Cefotaxime [Susceptibility] by Serum bactericidal titer |
|
41671-9
|
Cefotaxime+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
35769-9
|
Cefotaxime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
35770-7
|
Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35771-5
|
Cefotaxime+Clavulanate [Susceptibility] |
|
55644-9
|
Cefotaxime+Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
54193-8
|
Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54192-0
|
Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54191-2
|
Cefotaxime+Sulbactam [Susceptibility] |
|
31139-9
|
Cefotaxime.meningitis [Susceptibility] by Gradient strip (E-test) |
|
55189-5
|
Cefotaxime.meningitis [Susceptibility] by Disk diffusion (KB) |
|
31138-1
|
Cefotaxime.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
52128-6
|
Cefotaxime.meningitis [Susceptibility] |
|
6990-6
|
Cefotetan [Susceptibility] by Gradient strip (E-test) |
|
113-1
|
Cefotetan [Susceptibility] by Disk diffusion (KB) |
|
112-3
|
Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
111-5
|
Cefotetan [Susceptibility] by Minimum lethal concentration (MLC) |
|
18887-0
|
Cefotetan [Susceptibility] |
|
114-9
|
Cefotetan [Susceptibility] by Serum bactericidal titer |
|
41674-3
|
Cefotetan+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
41673-5
|
Cefotetan+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41672-7
|
Cefotetan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41729-5
|
Cefotetan+Clavulanate [Susceptibility] |
|
55740-5
|
Cefotiam hexetil [Susceptibility] by Gradient strip (E-test) |
|
55739-7
|
Cefotiam hexetil [Susceptibility] by Disk diffusion (KB) |
|
55737-1
|
Cefotiam hexetil [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55738-9
|
Cefotiam hexetil [Susceptibility] |
|
55645-6
|
Cefotiam [Susceptibility] by Gradient strip (E-test) |
|
35772-3
|
Cefotiam [Susceptibility] by Disk diffusion (KB) |
|
35773-1
|
Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32374-1
|
Cefotiam [Susceptibility] |
|
25220-5
|
Cefoxitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
6991-4
|
Cefoxitin [Susceptibility] by Gradient strip (E-test) |
|
117-2
|
Cefoxitin [Susceptibility] by Disk diffusion (KB) |
|
116-4
|
Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
115-6
|
Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC) |
|
25366-6
|
Cefoxitin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18888-8
|
Cefoxitin [Susceptibility] |
|
118-0
|
Cefoxitin [Susceptibility] by Serum bactericidal titer |
|
41677-6
|
Cefoxitin+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
41676-8
|
Cefoxitin+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41675-0
|
Cefoxitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41730-3
|
Cefoxitin+Clavulanate [Susceptibility] |
|
53820-7
|
Cefozopran [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
6992-2
|
Cefpirome [Susceptibility] by Gradient strip (E-test) |
|
8276-8
|
Cefpirome [Susceptibility] by Disk diffusion (KB) |
|
8275-0
|
Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
8274-3
|
Cefpirome [Susceptibility] by Minimum lethal concentration (MLC) |
|
18889-6
|
Cefpirome [Susceptibility] |
|
6650-6
|
Cefpirome [Susceptibility] by Serum bactericidal titer |
|
6993-0
|
Cefpodoxime [Susceptibility] by Gradient strip (E-test) |
|
121-4
|
Cefpodoxime [Susceptibility] by Disk diffusion (KB) |
|
120-6
|
Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
119-8
|
Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC) |
|
18890-4
|
Cefpodoxime [Susceptibility] |
|
122-2
|
Cefpodoxime [Susceptibility] by Serum bactericidal titer |
|
41678-4
|
Cefpodoxime+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
41680-0
|
Cefpodoxime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41679-2
|
Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41731-1
|
Cefpodoxime+Clavulanate [Susceptibility] |
|
6994-8
|
Cefprozil [Susceptibility] by Gradient strip (E-test) |
|
125-5
|
Cefprozil [Susceptibility] by Disk diffusion (KB) |
|
124-8
|
Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
123-0
|
Cefprozil [Susceptibility] by Minimum lethal concentration (MLC) |
|
18891-2
|
Cefprozil [Susceptibility] |
|
126-3
|
Cefprozil [Susceptibility] by Serum bactericidal titer |
|
55647-2
|
Cefsulodin [Susceptibility] by Gradient strip (E-test) |
|
129-7
|
Cefsulodin [Susceptibility] by Disk diffusion (KB) |
|
128-9
|
Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
127-1
|
Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18892-0
|
Cefsulodin [Susceptibility] |
|
130-5
|
Cefsulodin [Susceptibility] by Serum bactericidal titer |
|
6995-5
|
Ceftazidime [Susceptibility] by Gradient strip (E-test) |
|
134-7
|
Ceftazidime [Susceptibility] by Disk diffusion (KB) |
|
133-9
|
Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
132-1
|
Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC) |
|
58705-5
|
Ceftazidime [Susceptibility] by Method for Slow-growing mycobacteria |
|
18893-8
|
Ceftazidime [Susceptibility] |
|
135-4
|
Ceftazidime [Susceptibility] by Serum bactericidal titer |
|
42352-5
|
Ceftazidime+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
35774-9
|
Ceftazidime+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
35775-6
|
Ceftazidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35776-4
|
Ceftazidime+Clavulanate [Susceptibility] |
|
55651-4
|
Ceftazidime+Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
55650-6
|
Ceftazidime+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55648-0
|
Ceftazidime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55649-8
|
Ceftazidime+Sulbactam [Susceptibility] |
|
6996-3
|
Ceftibuten [Susceptibility] by Gradient strip (E-test) |
|
35777-2
|
Ceftibuten [Susceptibility] by Disk diffusion (KB) |
|
35778-0
|
Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35779-8
|
Ceftibuten [Susceptibility] |
|
55652-2
|
Ceftiofur [Susceptibility] by Gradient strip (E-test) |
|
35780-6
|
Ceftiofur [Susceptibility] by Disk diffusion (KB) |
|
35781-4
|
Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23709-9
|
Ceftiofur [Susceptibility] |
|
6997-1
|
Ceftizoxime [Susceptibility] by Gradient strip (E-test) |
|
138-8
|
Ceftizoxime [Susceptibility] by Disk diffusion (KB) |
|
137-0
|
Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
136-2
|
Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC) |
|
20378-6
|
Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria |
|
18894-6
|
Ceftizoxime [Susceptibility] |
|
139-6
|
Ceftizoxime [Susceptibility] by Serum bactericidal titer |
|
43269-0
|
Ceftobiprole [Susceptibility] by Disk diffusion (KB) |
|
43271-6
|
Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
43270-8
|
Ceftobiprole [Susceptibility] by Minimum lethal concentration (MLC) |
|
43272-4
|
Ceftobiprole [Susceptibility] |
|
6998-9
|
Ceftriaxone [Susceptibility] by Gradient strip (E-test) |
|
142-0
|
Ceftriaxone [Susceptibility] by Disk diffusion (KB) |
|
141-2
|
Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
140-4
|
Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC) |
|
25367-4
|
Ceftriaxone [Susceptibility] by Method for Slow-growing mycobacteria |
|
18895-3
|
Ceftriaxone [Susceptibility] |
|
143-8
|
Ceftriaxone [Susceptibility] by Serum bactericidal titer |
|
41683-4
|
Ceftriaxone+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
41682-6
|
Ceftriaxone+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41681-8
|
Ceftriaxone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41732-9
|
Ceftriaxone+Clavulanate [Susceptibility] |
|
31141-5
|
Ceftriaxone.meningitis [Susceptibility] by Gradient strip (E-test) |
|
55190-3
|
Ceftriaxone.meningitis [Susceptibility] by Disk diffusion (KB) |
|
31140-7
|
Ceftriaxone.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
50633-7
|
Ceftriaxone.meningitis [Susceptibility] |
|
55654-8
|
Cefuroxime [Susceptibility] by Gradient strip (E-test) |
|
51774-8
|
Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55653-0
|
Cefuroxime Oral [Susceptibility] by Gradient strip (E-test) |
|
35782-2
|
Cefuroxime Oral [Susceptibility] by Disk diffusion (KB) |
|
20460-2
|
Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35783-0
|
Cefuroxime Oral [Susceptibility] |
|
6999-7
|
Cefuroxime Parenteral [Susceptibility] by Gradient strip (E-test) |
|
146-1
|
Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB) |
|
145-3
|
Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
144-6
|
Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC) |
|
18896-1
|
Cefuroxime Parenteral [Susceptibility] |
|
147-9
|
Cefuroxime Parenteral [Susceptibility] by Serum bactericidal titer |
|
51724-3
|
Cefuroxime [Susceptibility] |
|
35784-8
|
Cephalexin [Susceptibility] by Gradient strip (E-test) |
|
150-3
|
Cephalexin [Susceptibility] by Disk diffusion (KB) |
|
149-5
|
Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
148-7
|
Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18897-9
|
Cephalexin [Susceptibility] |
|
151-1
|
Cephalexin [Susceptibility] by Serum bactericidal titer |
|
55629-0
|
Cephaloglycin [Susceptibility] by Gradient strip (E-test) |
|
154-5
|
Cephaloglycin [Susceptibility] by Disk diffusion (KB) |
|
153-7
|
Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
152-9
|
Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18898-7
|
Cephaloglycin [Susceptibility] |
|
155-2
|
Cephaloglycin [Susceptibility] by Serum bactericidal titer |
|
41684-2
|
Cephaloridine [Susceptibility] by Gradient strip (E-test) |
|
158-6
|
Cephaloridine [Susceptibility] by Disk diffusion (KB) |
|
157-8
|
Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
156-0
|
Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18899-5
|
Cephaloridine [Susceptibility] |
|
159-4
|
Cephaloridine [Susceptibility] by Serum bactericidal titer |
|
62257-1
|
Cephalosporin resistance gene [Presence] by Probe & target amplification method |
|
7000-3
|
Cephalothin [Susceptibility] by Gradient strip (E-test) |
|
162-8
|
Cephalothin [Susceptibility] by Disk diffusion (KB) |
|
161-0
|
Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
160-2
|
Cephalothin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18900-1
|
Cephalothin [Susceptibility] |
|
163-6
|
Cephalothin [Susceptibility] by Serum bactericidal titer |
|
55633-2
|
Cephalothin+Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
55632-4
|
Cephalothin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55630-8
|
Cephalothin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55631-6
|
Cephalothin+Sulbactam [Susceptibility] |
|
55638-1
|
Cephapirin [Susceptibility] by Gradient strip (E-test) |
|
166-9
|
Cephapirin [Susceptibility] by Disk diffusion (KB) |
|
165-1
|
Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
164-4
|
Cephapirin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18901-9
|
Cephapirin [Susceptibility] |
|
167-7
|
Cephapirin [Susceptibility] by Serum bactericidal titer |
|
55646-4
|
Cephradine [Susceptibility] by Gradient strip (E-test) |
|
170-1
|
Cephradine [Susceptibility] by Disk diffusion (KB) |
|
169-3
|
Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
168-5
|
Cephradine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18902-7
|
Cephradine [Susceptibility] |
|
171-9
|
Cephradine [Susceptibility] by Serum bactericidal titer |
|
7001-1
|
Chloramphenicol [Susceptibility] by Gradient strip (E-test) |
|
174-3
|
Chloramphenicol [Susceptibility] by Disk diffusion (KB) |
|
173-5
|
Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
172-7
|
Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC) |
|
18903-5
|
Chloramphenicol [Susceptibility] |
|
175-0
|
Chloramphenicol [Susceptibility] by Serum bactericidal titer |
|
55655-5
|
Chlortetracycline [Susceptibility] by Gradient strip (E-test) |
|
178-4
|
Chlortetracycline [Susceptibility] by Disk diffusion (KB) |
|
177-6
|
Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
176-8
|
Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18904-3
|
Chlortetracycline [Susceptibility] |
|
179-2
|
Chlortetracycline [Susceptibility] by Serum bactericidal titer |
|
33628-9
|
Cidofovir [Susceptibility] |
|
55656-3
|
Cinoxacin [Susceptibility] by Gradient strip (E-test) |
|
182-6
|
Cinoxacin [Susceptibility] by Disk diffusion (KB) |
|
181-8
|
Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
180-0
|
Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18905-0
|
Cinoxacin [Susceptibility] |
|
183-4
|
Cinoxacin [Susceptibility] by Serum bactericidal titer |
|
55194-5
|
Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25180-1
|
Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25181-9
|
Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25189-2
|
Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25188-4
|
Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7002-9
|
Ciprofloxacin [Susceptibility] by Gradient strip (E-test) |
|
186-7
|
Ciprofloxacin [Susceptibility] by Disk diffusion (KB) |
|
185-9
|
Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
184-2
|
Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20377-8
|
Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18906-8
|
Ciprofloxacin [Susceptibility] |
|
187-5
|
Ciprofloxacin [Susceptibility] by Serum bactericidal titer |
|
43987-7
|
Clarithromycin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25191-8
|
Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
43990-1
|
Clarithromycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25192-6
|
Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
43991-9
|
Clarithromycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25190-0
|
Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7003-7
|
Clarithromycin [Susceptibility] by Gradient strip (E-test) |
|
190-9
|
Clarithromycin [Susceptibility] by Disk diffusion (KB) |
|
189-1
|
Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
188-3
|
Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20375-2
|
Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18907-6
|
Clarithromycin [Susceptibility] |
|
191-7
|
Clarithromycin [Susceptibility] by Serum bactericidal titer |
|
16620-7
|
Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41685-9
|
Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
41686-7
|
Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
41687-5
|
Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41733-7
|
Clavulanate [Susceptibility] |
|
7004-5
|
Clinafloxacin [Susceptibility] by Gradient strip (E-test) |
|
35785-5
|
Clinafloxacin [Susceptibility] by Disk diffusion (KB) |
|
35786-3
|
Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32376-6
|
Clinafloxacin [Susceptibility] |
|
7005-2
|
Clindamycin [Susceptibility] by Gradient strip (E-test) |
|
194-1
|
Clindamycin [Susceptibility] by Disk diffusion (KB) |
|
193-3
|
Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
192-5
|
Clindamycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18908-4
|
Clindamycin [Susceptibility] |
|
195-8
|
Clindamycin [Susceptibility] by Serum bactericidal titer |
|
55658-9
|
Clindamycin.high potency [Susceptibility] by Gradient strip (E-test) |
|
55659-7
|
Clindamycin.high potency [Susceptibility] by Disk diffusion (KB) |
|
55660-5
|
Clindamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55657-1
|
Clindamycin.high potency [Susceptibility] |
|
42720-3
|
Clindamycin.induced [Susceptibility] by Disk diffusion (KB) |
|
43988-5
|
Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
43989-3
|
Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
43986-9
|
Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55662-1
|
Clofazimine [Susceptibility] by Gradient strip (E-test) |
|
55661-3
|
Clofazimine [Susceptibility] by Disk diffusion (KB) |
|
16623-1
|
Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
20376-0
|
Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria |
|
23627-3
|
Clofazimine [Susceptibility] |
|
55663-9
|
Clotrimazole [Susceptibility] by Gradient strip (E-test) |
|
54177-1
|
Clotrimazole [Susceptibility] by Disk diffusion (KB) |
|
10653-4
|
Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
10654-2
|
Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18909-2
|
Clotrimazole [Susceptibility] |
|
55664-7
|
Cloxacillin [Susceptibility] by Gradient strip (E-test) |
|
198-2
|
Cloxacillin [Susceptibility] by Disk diffusion (KB) |
|
197-4
|
Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
196-6
|
Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18910-0
|
Cloxacillin [Susceptibility] |
|
199-0
|
Cloxacillin [Susceptibility] by Serum bactericidal titer |
|
40444-2
|
CMV gene mutations detected [Identifier] in Isolate |
|
33631-3
|
Cytomegalovirus UL54 gene mutations detected [Identifier] in Isolate |
|
33632-1
|
Cytomegalovirus UL54+UL97 gene mutations detected [Identifier] in Isolate |
|
55665-4
|
Colistimethate by Gradient strip (E-test) |
|
202-2
|
Colistimethate by Disk diffusion (KB) |
|
201-4
|
Colistimethate by Minimum inhibitory concentration (MIC) |
|
200-6
|
Colistimethate by Minimum lethal concentration (MLC) |
|
18911-8
|
Colistimethate |
|
203-0
|
Colistimethate [Susceptibility] by Serum bactericidal titer |
|
33333-6
|
Colistin [Susceptibility] by Gradient strip (E-test) |
|
206-3
|
Colistin [Susceptibility] by Disk diffusion (KB) |
|
205-5
|
Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
204-8
|
Colistin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18912-6
|
Colistin [Susceptibility] |
|
207-1
|
Colistin [Susceptibility] by Serum bactericidal titer |
|
55666-2
|
Cyclacillin [Susceptibility] by Gradient strip (E-test) |
|
210-5
|
Cyclacillin [Susceptibility] by Disk diffusion (KB) |
|
209-7
|
Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
208-9
|
Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18913-4
|
Cyclacillin [Susceptibility] |
|
211-3
|
Cyclacillin [Susceptibility] by Serum bactericidal titer |
|
25207-2
|
Cycloserine 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25208-0
|
Cycloserine 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25209-8
|
Cycloserine 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55667-0
|
Cycloserine [Susceptibility] by Gradient strip (E-test) |
|
214-7
|
Cycloserine [Susceptibility] by Disk diffusion (KB) |
|
213-9
|
Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
212-1
|
Cycloserine [Susceptibility] by Minimum lethal concentration (MLC) |
|
23608-3
|
Cycloserine [Susceptibility] by Method for Slow-growing mycobacteria |
|
18914-2
|
Cycloserine [Susceptibility] |
|
215-4
|
Cycloserine [Susceptibility] by Serum bactericidal titer |
|
41690-9
|
Dalbavancin [Susceptibility] by Gradient strip (E-test) |
|
41688-3
|
Dalbavancin [Susceptibility] by Disk diffusion (KB) |
|
41689-1
|
Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41734-5
|
Dalbavancin [Susceptibility] |
|
41691-7
|
Daptomycin [Susceptibility] by Gradient strip (E-test) |
|
35787-1
|
Daptomycin [Susceptibility] by Disk diffusion (KB) |
|
35788-9
|
Daptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35789-7
|
Daptomycin [Susceptibility] |
|
55091-3
|
Darunavir [Susceptibility] by Genotype method |
|
49666-1
|
Darunavir [Susceptibility] by Phenotype method |
|
49630-7
|
Darunavir+Ritonavir [Susceptibility] by Genotype method |
|
57955-7
|
Darunavir+Ritonavir [Susceptibility] by Phenotype method |
|
51698-9
|
Dapsone [Susceptibility] |
|
30290-1
|
Delavirdine [Susceptibility] by Genotype method |
|
30276-0
|
Delavirdine [Susceptibility] by Phenotype method |
|
30305-7
|
Delavirdine [Susceptibility] |
|
7006-0
|
Demeclocycline [Susceptibility] by Gradient strip (E-test) |
|
218-8
|
Demeclocycline [Susceptibility] by Disk diffusion (KB) |
|
217-0
|
Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
216-2
|
Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18915-9
|
Demeclocycline [Susceptibility] |
|
219-6
|
Demeclocycline [Susceptibility] by Serum bactericidal titer |
|
17831-9
|
Deprecated 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
17832-7
|
Deprecated 5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18925-8
|
Deprecated 5-Fluorocytosine [Susceptibility] |
|
33298-1
|
Deprecated Amdinocillin [Susceptibility] |
|
23624-0
|
Deprecated Amikacin [Susceptibility] by Slow-growing mycobacteria |
|
23618-2
|
Deprecated Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria |
|
42643-7
|
Deprecated Capreomycin 10.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
6645-7
|
Deprecated Cefepime [Susceptibility] by Disk diffusion (KB) |
|
6646-5
|
Deprecated Cefepime [Susceptibility] by Serum bactericidal titer |
|
6649-9
|
Deprecated Cefpirome [Susceptibility] by Disk diffusion (KB) |
|
6648-1
|
Deprecated Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
6647-3
|
Deprecated Cefpirome [Susceptibility] by Minimum lethal concentration (MLC) |
|
23622-4
|
Deprecated Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria |
|
42644-5
|
Deprecated Ciprofloxacin 2.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
23621-6
|
Deprecated Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
23619-0
|
Deprecated Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
33284-1
|
Deprecated Clinafloxacin [Susceptibility] |
|
23620-8
|
Deprecated Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria |
|
32380-8
|
Deprecated Dicloxacillin [Susceptibility] |
|
23623-2
|
Deprecated Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria |
|
23633-1
|
Deprecated Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
42645-2
|
Deprecated Ethambutol 10.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42646-0
|
Deprecated Ethambutol 5.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
23625-7
|
Deprecated Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria |
|
42647-8
|
Deprecated Ethionamide 10.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42648-6
|
Deprecated Ethionamide 5.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
23617-4
|
Deprecated Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria |
|
48559-9
|
Deprecated HIV gentotype [Susceptibility] |
|
284-0
|
Deprecated Imipenem+Cilastatin [Susceptibility] by Disk diffusion (KB) |
|
283-2
|
Deprecated Imipenem+Cilastatin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
282-4
|
Deprecated Imipenem+Cilastatin [Susceptibility] by Minimum lethal concentration (MLC) |
|
285-7
|
Deprecated Imipenem+Cilastatin [Susceptibility] by Serum bactericidal titer |
|
18933-2
|
Deprecated Imipenem+Cilastatin [Susceptibility] |
|
48171-3
|
Deprecated Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42649-4
|
Deprecated Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
48172-1
|
Deprecated Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42650-2
|
Deprecated Isoniazid 1.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
23947-5
|
Deprecated Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria |
|
42652-8
|
Deprecated Kanamycin 5.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
32382-4
|
Deprecated Nitroxoline [Susceptibility] |
|
42653-6
|
Deprecated Ofloxacin 2.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
23948-3
|
Deprecated Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
23817-0
|
Deprecated Other Antibiotic [Susceptibility] by Minimum lethal concentration (MLC) --peak |
|
23818-8
|
Deprecated Other Antibiotic [Susceptibility] by Minimum lethal concentration (MLC) --trough |
|
55700-9
|
Deprecated Paramomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
42654-4
|
Deprecated Para aminosalicylate 2.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42935-7
|
Deprecated Pyrazinamide 100.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
23632-3
|
Deprecated Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria |
|
42656-9
|
Deprecated Rifabutin 2.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
16386-5
|
Deprecated Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23630-7
|
Deprecated Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria |
|
42657-7
|
Deprecated Rifampin 1.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
23949-1
|
Deprecated Rifampin [Susceptibility] by Method for Slow-growing mycobacteria |
|
42658-5
|
Deprecated Streptomycin 10.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42659-3
|
Deprecated Streptomycin 2.0 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
23626-5
|
Deprecated Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
32633-0
|
Deprecated Susceptibility organism^^^4 |
|
56793-3
|
Deprecated Tenefovir [Susceptibility] by Genotype method |
|
23631-5
|
Deprecated Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria |
|
55672-0
|
Dibekacin [Susceptibility] by Gradient strip (E-test) |
|
55671-2
|
Dibekacin [Susceptibility] by Disk diffusion (KB) |
|
55669-6
|
Dibekacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55670-4
|
Dibekacin [Susceptibility] |
|
55668-8
|
Dicloxacillin [Susceptibility] by Gradient strip (E-test) |
|
222-0
|
Dicloxacillin [Susceptibility] by Disk diffusion (KB) |
|
221-2
|
Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
220-4
|
Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18916-7
|
Dicloxacillin [Susceptibility] |
|
223-8
|
Dicloxacillin [Susceptibility] by Serum bactericidal titer |
|
30284-4
|
Didanosine [Susceptibility] by Genotype method |
|
30270-3
|
Didanosine [Susceptibility] by Phenotype method |
|
30300-8
|
Didanosine [Susceptibility] |
|
35790-5
|
Difloxacin [Susceptibility] by Disk diffusion (KB) |
|
35791-3
|
Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35792-1
|
Difloxacin [Susceptibility] |
|
7007-8
|
Dirithromycin [Susceptibility] by Gradient strip (E-test) |
|
35793-9
|
Dirithromycin [Susceptibility] by Disk diffusion (KB) |
|
35794-7
|
Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35795-4
|
Dirithromycin [Susceptibility] |
|
58711-3
|
Doripenem [Susceptibility] by Gradient strip (E-test) |
|
56031-8
|
Doripenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
60535-2
|
Doripenem [Susceptibility] |
|
25223-9
|
Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7008-6
|
Doxycycline [Susceptibility] by Gradient strip (E-test) |
|
226-1
|
Doxycycline [Susceptibility] by Disk diffusion (KB) |
|
225-3
|
Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
224-6
|
Doxycycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
20379-4
|
Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria |
|
18917-5
|
Doxycycline [Susceptibility] |
|
227-9
|
Doxycycline [Susceptibility] by Serum bactericidal titer |
|
55673-8
|
Econazole [Susceptibility] by Gradient strip (E-test) |
|
54178-9
|
Econazole [Susceptibility] by Disk diffusion (KB) |
|
25637-0
|
Econazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25595-0
|
Econazole [Susceptibility] |
|
30291-9
|
Efavirenz [Susceptibility] by Genotype method |
|
30277-8
|
Efavirenz [Susceptibility] by Phenotype method |
|
30306-5
|
Efavirenz [Susceptibility] |
|
41402-9
|
Emtricitabine [Susceptibility] by Genotype method |
|
49669-5
|
Emtricitabine [Susceptibility] by Phenotype method |
|
41692-5
|
Enoxacin [Susceptibility] by Gradient strip (E-test) |
|
230-3
|
Enoxacin [Susceptibility] by Disk diffusion (KB) |
|
229-5
|
Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
228-7
|
Enoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18918-3
|
Enoxacin [Susceptibility] |
|
231-1
|
Enoxacin [Susceptibility] by Serum bactericidal titer |
|
35796-2
|
Enrofloxacin [Susceptibility] by Gradient strip (E-test) |
|
35797-0
|
Enrofloxacin [Susceptibility] by Disk diffusion (KB) |
|
35798-8
|
Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23712-3
|
Enrofloxacin [Susceptibility] |
|
56791-7
|
Entecavir [Susceptibility] by Genotype method |
|
35800-2
|
Ertapenem [Susceptibility] by Gradient strip (E-test) |
|
35799-6
|
Ertapenem [Susceptibility] by Disk diffusion (KB) |
|
35801-0
|
Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35802-8
|
Ertapenem [Susceptibility] |
|
16830-2
|
Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
11576-6
|
Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip (E-test) |
|
238-6
|
Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB) |
|
237-8
|
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
236-0
|
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18920-9
|
Erythromycin+Sulfisoxazole [Susceptibility] |
|
239-4
|
Erythromycin+Sulfisoxazole [Susceptibility] by Serum bactericidal titer |
|
25224-7
|
Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7009-4
|
Erythromycin [Susceptibility] by Gradient strip (E-test) |
|
234-5
|
Erythromycin [Susceptibility] by Disk diffusion (KB) |
|
233-7
|
Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
232-9
|
Erythromycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20380-2
|
Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18919-1
|
Erythromycin [Susceptibility] |
|
235-2
|
Erythromycin [Susceptibility] by Serum bactericidal titer |
|
62258-9
|
Erythromyin/Clindamycin resistance gene [Presence] by Probe & target amplification method |
|
25195-9
|
Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55674-6
|
Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25230-4
|
Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25194-2
|
Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25187-6
|
Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
56025-0
|
Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7010-2
|
Ethambutol [Susceptibility] by Gradient strip (E-test) |
|
242-8
|
Ethambutol [Susceptibility] by Disk diffusion (KB) |
|
241-0
|
Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
240-2
|
Ethambutol [Susceptibility] by Minimum lethal concentration (MLC) |
|
20381-0
|
Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria |
|
18921-7
|
Ethambutol [Susceptibility] |
|
243-6
|
Ethambutol [Susceptibility] by Serum bactericidal titer |
|
16841-9
|
Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55154-9
|
Ethambutol+Rifampin [Susceptibility] by Method for Slow-growing mycobacteria |
|
25231-2
|
Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25183-5
|
Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25198-3
|
Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25196-7
|
Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7011-0
|
Ethionamide [Susceptibility] by Gradient strip (E-test) |
|
41693-3
|
Ethionamide [Susceptibility] by Disk diffusion (KB) |
|
16099-4
|
Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
20382-8
|
Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria |
|
18922-5
|
Ethionamide [Susceptibility] |
|
52749-9
|
Etravirine [Susceptibility] by Genotype method |
|
41695-8
|
Everninomicin [Susceptibility] by Gradient strip (E-test) |
|
41696-6
|
Everninomicin [Susceptibility] by Disk diffusion (KB) |
|
41694-1
|
Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41735-2
|
Everninomicin [Susceptibility] |
|
7012-8
|
Fleroxacin [Susceptibility] by Gradient strip (E-test) |
|
35806-9
|
Fleroxacin [Susceptibility] by Disk diffusion (KB) |
|
25411-0
|
Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32372-5
|
Fleroxacin [Susceptibility] |
|
53822-3
|
Flomoxef [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35807-7
|
Florfenicol [Susceptibility] by Disk diffusion (KB) |
|
35808-5
|
Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23740-4
|
Florfenicol [Susceptibility] |
|
246-9
|
Floxacillin [Susceptibility] by Disk diffusion (KB) |
|
245-1
|
Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
244-4
|
Floxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18923-3
|
Floxacillin [Susceptibility] |
|
247-7
|
Floxacillin [Susceptibility] by Serum bactericidal titer |
|
57896-3
|
Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] by Genotype method |
|
50699-8
|
Influenza virus A.adamantane resistance [Presence] |
|
50698-0
|
Influenza virus A.adamantane resistance [Presence] by Phenotype method |
|
50700-4
|
Influenza virus A.adamantane resistant RNA [Presence] by Probe & target amplification method |
|
57895-5
|
Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] by Genotype method |
|
50703-8
|
Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative by Phenotype method |
|
57897-1
|
Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] by Genotype method |
|
7013-6
|
Fluconazole [Susceptibility] by Gradient strip (E-test) |
|
250-1
|
Fluconazole [Susceptibility] by Disk diffusion (KB) |
|
249-3
|
Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
248-5
|
Fluconazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18924-1
|
Fluconazole [Susceptibility] |
|
251-9
|
Fluconazole [Susceptibility] by Serum bactericidal titer |
|
55678-7
|
Flumequine [Susceptibility] by Gradient strip (E-test) |
|
55677-9
|
Flumequine [Susceptibility] by Disk diffusion (KB) |
|
55675-3
|
Flumequine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55676-1
|
Flumequine [Susceptibility] |
|
50713-7
|
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype method |
|
50712-9
|
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] Qualitative |
|
50710-3
|
Influenza virus susceptibility panel in Isolate |
|
43736-8
|
Fosamprenavir [Susceptibility] by Genotype method |
|
42500-9
|
Fosamprenavir [Susceptibility] by Phenotype method |
|
51409-1
|
Fosamprenavir+Ritonavir [Susceptibility] by Genotype method |
|
57965-6
|
Fosamprenavir+Ritonavir [Susceptibility] by Phenotype method |
|
42317-8
|
Foscarnet [Susceptibility] by Genotype method |
|
256-8
|
Foscarnet [Susceptibility] |
|
35809-3
|
Fosfomycin [Susceptibility] by Gradient strip (E-test) |
|
35810-1
|
Fosfomycin [Susceptibility] by Disk diffusion (KB) |
|
25653-7
|
Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25596-8
|
Fosfomycin [Susceptibility] |
|
55679-5
|
Framycetin [Susceptibility] by Gradient strip (E-test) |
|
259-2
|
Framycetin [Susceptibility] by Disk diffusion (KB) |
|
258-4
|
Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
257-6
|
Framycetin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18926-6
|
Framycetin [Susceptibility] |
|
260-0
|
Framycetin [Susceptibility] by Serum bactericidal titer |
|
29577-4
|
Fungal susceptibility panel in Isolate |
|
20388-5
|
Furacin.topical [Susceptibility] |
|
7015-1
|
Fusidate [Susceptibility] by Gradient strip (E-test) |
|
263-4
|
Fusidate [Susceptibility] by Disk diffusion (KB) |
|
262-6
|
Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
261-8
|
Fusidate [Susceptibility] by Minimum lethal concentration (MLC) |
|
18927-4
|
Fusidate [Susceptibility] |
|
264-2
|
Fusidate [Susceptibility] by Serum bactericidal titer |
|
265-9
|
Ganciclovir [Susceptibility] |
|
35811-9
|
Garenoxacin [Susceptibility] by Disk diffusion (KB) |
|
35812-7
|
Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35813-5
|
Garenoxacin [Susceptibility] |
|
31042-5
|
Gatifloxacin [Susceptibility] by Gradient strip (E-test) |
|
31040-9
|
Gatifloxacin [Susceptibility] by Disk diffusion (KB) |
|
31036-7
|
Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41494-6
|
Gatifloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
31038-3
|
Gatifloxacin [Susceptibility] |
|
41697-4
|
Gemifloxacin [Susceptibility] by Gradient strip (E-test) |
|
35814-3
|
Gemifloxacin [Susceptibility] by Disk diffusion (KB) |
|
35815-0
|
Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35816-8
|
Gemifloxacin [Susceptibility] |
|
7016-9
|
Gentamicin [Susceptibility] by Gradient strip (E-test) |
|
268-3
|
Gentamicin [Susceptibility] by Disk diffusion (KB) |
|
267-5
|
Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
266-7
|
Gentamicin [Susceptibility] by Minimum lethal concentration (MLC) |
|
50630-3
|
Gentamicin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18928-2
|
Gentamicin [Susceptibility] |
|
35817-6
|
Gentamicin.high potency [Susceptibility] by Gradient strip (E-test) |
|
7017-7
|
Gentamicin.high potency [Susceptibility] by Disk diffusion (KB) |
|
7018-5
|
Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
18929-0
|
Gentamicin.high potency [Susceptibility] |
|
269-1
|
Gentamicin [Susceptibility] by Serum bactericidal titer |
|
272-5
|
Gramicidin D [Susceptibility] by Disk diffusion (KB) |
|
271-7
|
Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
270-9
|
Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC) |
|
18930-8
|
Gramicidin D [Susceptibility] |
|
273-3
|
Gramicidin D [Susceptibility] by Serum bactericidal titer |
|
21316-5
|
Grepafloxacin [Susceptibility] by Gradient strip (E-test) |
|
35818-4
|
Grepafloxacin [Susceptibility] by Disk diffusion (KB) |
|
23639-8
|
Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23638-0
|
Grepafloxacin [Susceptibility] |
|
54202-7
|
Griseofulvin [Susceptibility] by Disk diffusion (KB) |
|
54201-9
|
Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54200-1
|
Griseofulvin [Susceptibility] |
|
49877-4
|
Hepatitis B virus codon 173 [Identifier] in Isolate by Genotype method |
|
49878-2
|
Hepatitis B virus codon 180 [Identifier] in Isolate by Genotype method |
|
49880-8
|
Hepatitis B virus codon 204 [Identifier] in Isolate by Genotype method |
|
49881-6
|
Hepatitis B virus codon 236 [Identifier] in Isolate by Genotype method |
|
49882-4
|
Hepatitis B virus codon 80 [Identifier] in Isolate by Genotype method |
|
49883-2
|
Hepatitis B virus susceptibility panel in Isolate by Genotype method |
|
276-6
|
Hetacillin [Susceptibility] by Disk diffusion (KB) |
|
275-8
|
Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
274-1
|
Hetacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18931-6
|
Hetacillin [Susceptibility] |
|
277-4
|
Hetacillin [Susceptibility] by Serum bactericidal titer |
|
48558-1
|
HIV gentotype [Susceptibility] |
|
49573-9
|
HIV genotype [Susceptibility] in Isolate by Genotype method Narrative |
|
49660-4
|
HIV genotype panel in Isolate by Genotype method |
|
61199-6
|
HIV integrase gene mutations detected [Identifier] in Isolate |
|
45176-5
|
HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier] in Isolate |
|
49657-0
|
HIV nonnucleoside reverse transcriptase mutations in Isolate by Genotype method |
|
49662-0
|
HIV nonnucleoside reverse transcriptase mutations in Isolate by Phenotype method |
|
45175-7
|
HIV nucleoside reverse transcriptase gene mutations detected [Identifier] in Isolate |
|
49658-8
|
HIV nucleoside reverse transcriptase mutations in Isolate by Genotype method |
|
49663-8
|
HIV nucleoside reverse transcriptase mutations in Isolate by Phenotype method |
|
45182-3
|
HIV phenotype [Susceptibility] |
|
49665-3
|
HIV phenotype panel in Isolate by Phenotype method |
|
33630-5
|
HIV protease gene mutations detected [Identifier] in Isolate |
|
49656-2
|
HIV protease gene mutations by Genotype method |
|
49661-2
|
HIV protease gene mutations by Phenotype method |
|
30554-0
|
HIV reverse transcriptase gene mutations detected [Identifier] in Isolate |
|
49659-6
|
HIV reverse transcriptase mutations by Genotype method |
|
49664-6
|
HIV reverse transcriptase mutations by Phenotype method |
|
53798-5
|
HIV Reverse Transcriptase+Protease genes mutations detected [Identifier] in Isolate |
|
34700-5
|
HIV Reverse Transcriptase+Protease genes mutations tested for in Isolate |
|
49879-0
|
Hepatitis B virus codon 181 [Identifier] in Isolate by Genotype method |
|
25221-3
|
Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7019-3
|
Imipenem [Susceptibility] by Gradient strip (E-test) |
|
280-8
|
Imipenem [Susceptibility] by Disk diffusion (KB) |
|
279-0
|
Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
278-2
|
Imipenem [Susceptibility] by Minimum lethal concentration (MLC) |
|
23613-3
|
Imipenem [Susceptibility] by Method for Slow-growing mycobacteria |
|
18932-4
|
Imipenem [Susceptibility] |
|
281-6
|
Imipenem [Susceptibility] by Serum bactericidal titer |
|
35819-2
|
Imipenem+EDTA [Susceptibility] by Gradient strip (E-test) |
|
54172-2
|
Imipenem+EDTA [Susceptibility] by Disk diffusion (KB) |
|
54171-4
|
Imipenem+EDTA [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54170-6
|
Imipenem+EDTA [Susceptibility] |
|
30292-7
|
Indinavir [Susceptibility] by Genotype method |
|
30278-6
|
Indinavir [Susceptibility] by Phenotype method |
|
30307-3
|
Indinavir [Susceptibility] |
|
49619-0
|
Indinavir+Ritonavir [Susceptibility] by Genotype method |
|
57984-7
|
Indinavir+Ritonavir [Susceptibility] by Phenotype method |
|
55680-3
|
Isepamicin [Susceptibility] by Gradient strip (E-test) |
|
35820-0
|
Isepamicin [Susceptibility] by Disk diffusion (KB) |
|
35821-8
|
Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32381-6
|
Isepamicin [Susceptibility] |
|
55684-5
|
Isoconazole [Susceptibility] by Gradient strip (E-test) |
|
55683-7
|
Isoconazole [Susceptibility] by Disk diffusion (KB) |
|
55681-1
|
Isoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55682-9
|
Isoconazole [Susceptibility] |
|
25217-1
|
Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25218-9
|
Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
29315-9
|
Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25219-7
|
Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55685-2
|
Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
45215-1
|
Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
42651-0
|
Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7020-1
|
Isoniazid [Susceptibility] by Gradient strip (E-test) |
|
288-1
|
Isoniazid [Susceptibility] by Disk diffusion (KB) |
|
287-3
|
Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
286-5
|
Isoniazid [Susceptibility] by Minimum lethal concentration (MLC) |
|
20383-6
|
Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria |
|
18934-0
|
Isoniazid [Susceptibility] |
|
289-9
|
Isoniazid [Susceptibility] by Serum bactericidal titer |
|
7021-9
|
Itraconazole [Susceptibility] by Gradient strip (E-test) |
|
54179-7
|
Itraconazole [Susceptibility] by Disk diffusion (KB) |
|
25452-4
|
Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32603-3
|
Itraconazole [Susceptibility] |
|
41699-0
|
Josamycine [Susceptibility] by Gradient strip (E-test) |
|
41698-2
|
Josamycine [Susceptibility] by Disk diffusion (KB) |
|
25702-2
|
Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25597-6
|
Josamycine [Susceptibility] |
|
49080-5
|
Kanamycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25214-8
|
Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25182-7
|
Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25213-0
|
Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7023-5
|
Kanamycin.high potency [Susceptibility] by Disk diffusion (KB) |
|
7024-3
|
Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
18936-5
|
Kanamycin.high potency [Susceptibility] |
|
7022-7
|
Kanamycin [Susceptibility] by Gradient strip (E-test) |
|
292-3
|
Kanamycin [Susceptibility] by Disk diffusion (KB) |
|
291-5
|
Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
290-7
|
Kanamycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23609-1
|
Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18935-7
|
Kanamycin [Susceptibility] |
|
293-1
|
Kanamycin [Susceptibility] by Serum bactericidal titer |
|
7025-0
|
Ketoconazole [Susceptibility] by Gradient strip (E-test) |
|
296-4
|
Ketoconazole [Susceptibility] by Disk diffusion (KB) |
|
295-6
|
Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
294-9
|
Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18937-3
|
Ketoconazole [Susceptibility] |
|
297-2
|
Ketoconazole [Susceptibility] by Serum bactericidal titer |
|
30283-6
|
Lamivudine [Susceptibility] by Genotype method |
|
30269-5
|
Lamivudine [Susceptibility] by Phenotype method |
|
30298-4
|
Lamivudine [Susceptibility] |
|
49620-8
|
Lamivudine or Emtricitabine [Susceptibility] by Genotype method |
|
48173-9
|
Levofloxacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7026-8
|
Levofloxacin [Susceptibility] by Gradient strip (E-test) |
|
21367-8
|
Levofloxacin [Susceptibility] by Disk diffusion (KB) |
|
20396-8
|
Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
53716-7
|
Levofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
20629-2
|
Levofloxacin [Susceptibility] |
|
41700-6
|
Lincomycin [Susceptibility] by Gradient strip (E-test) |
|
300-4
|
Lincomycin [Susceptibility] by Disk diffusion (KB) |
|
299-8
|
Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
298-0
|
Lincomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18938-1
|
Lincomycin [Susceptibility] |
|
301-2
|
Lincomycin [Susceptibility] by Serum bactericidal titer |
|
33332-8
|
Linezolid [Susceptibility] by Gradient strip (E-test) |
|
29255-7
|
Linezolid [Susceptibility] by Disk diffusion (KB) |
|
29254-0
|
Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41500-0
|
Linezolid [Susceptibility] by Method for Slow-growing mycobacteria |
|
29258-1
|
Linezolid [Susceptibility] |
|
55294-3
|
Linopristin+Flopristin [Susceptibility] by Disk diffusion (KB) |
|
55293-5
|
Linopristin+Flopristin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55292-7
|
Linopristin+Flopristin [Susceptibility] |
|
41701-4
|
Lomefloxacin [Susceptibility] by Gradient strip (E-test) |
|
304-6
|
Lomefloxacin [Susceptibility] by Disk diffusion (KB) |
|
303-8
|
Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
302-0
|
Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18939-9
|
Lomefloxacin [Susceptibility] |
|
305-3
|
Lomefloxacin [Susceptibility] by Serum bactericidal titer |
|
41031-6
|
Lopinavir [Susceptibility] by Genotype method |
|
34643-7
|
Lopinavir [Susceptibility] by Phenotype method |
|
42000-0
|
Lopinavir+Ritonavir [Susceptibility] by Genotype method |
|
57997-9
|
Lopinavir+Ritonavir [Susceptibility] by Phenotype method |
|
7027-6
|
Loracarbef [Susceptibility] by Gradient strip (E-test) |
|
308-7
|
Loracarbef [Susceptibility] by Disk diffusion (KB) |
|
307-9
|
Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
306-1
|
Loracarbef [Susceptibility] by Minimum lethal concentration (MLC) |
|
18940-7
|
Loracarbef [Susceptibility] |
|
309-5
|
Loracarbef [Susceptibility] by Serum bactericidal titer |
|
312-9
|
Lymecycline [Susceptibility] by Disk diffusion (KB) |
|
311-1
|
Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
310-3
|
Lymecycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18941-5
|
Lymecycline [Susceptibility] |
|
313-7
|
Lymecycline [Susceptibility] by Serum bactericidal titer |
|
46247-3
|
Mycobacterium tuberculosis DNA embB [Identifier] in Isolate by Probe & target amplification method |
|
48175-4
|
Mycobacterium tuberculosis.isoniazid resistant [Presence] by Probe & target amplification method |
|
46246-5
|
Mycobacterium tuberculosis DNA katG [Identifier] in Isolate by Probe & target amplification method |
|
46245-7
|
Mycobacterium tuberculosis DNA pncA [Identifier] in Isolate by Probe & target amplification method |
|
33634-7
|
Mycobacterium tuberculosis.rifampin resistant [Identifier] in Sputum by Probe & target amplification method |
|
48176-2
|
Mycobacterium tuberculosis.rifampin resistant [Presence] by Probe & target amplification method |
|
46244-0
|
Mycobacterium tuberculosis DNA rpoB [Identifier] in Isolate by Probe & target amplification method |
|
20391-9
|
Mafenide [Susceptibility] |
|
48813-0
|
mecA gene [Presence] by Probe & target amplification method |
|
316-0
|
Meclocycline [Susceptibility] by Disk diffusion (KB) |
|
315-2
|
Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
314-5
|
Meclocycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18942-3
|
Meclocycline [Susceptibility] |
|
317-8
|
Meclocycline [Susceptibility] by Serum bactericidal titer |
|
7029-2
|
Meropenem [Susceptibility] by Gradient strip (E-test) |
|
6653-0
|
Meropenem [Susceptibility] by Disk diffusion (KB) |
|
6652-2
|
Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
6651-4
|
Meropenem [Susceptibility] by Minimum lethal concentration (MLC) |
|
18943-1
|
Meropenem [Susceptibility] |
|
6654-8
|
Meropenem [Susceptibility] by Serum bactericidal titer |
|
320-2
|
Methacycline [Susceptibility] by Disk diffusion (KB) |
|
319-4
|
Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
318-6
|
Methacycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18944-9
|
Methacycline [Susceptibility] |
|
321-0
|
Methacycline [Susceptibility] by Serum bactericidal titer |
|
7030-0
|
Methicillin [Susceptibility] by Gradient strip (E-test) |
|
324-4
|
Methicillin [Susceptibility] by Disk diffusion (KB) |
|
323-6
|
Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
322-8
|
Methicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
62259-7
|
Methicillin resistance gene [Presence] by Probe & target amplification method |
|
18945-6
|
Methicillin [Susceptibility] |
|
325-1
|
Methicillin [Susceptibility] by Serum bactericidal titer |
|
7031-8
|
Metronidazole [Susceptibility] by Gradient strip (E-test) |
|
328-5
|
Metronidazole [Susceptibility] by Disk diffusion (KB) |
|
327-7
|
Metronidazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
326-9
|
Metronidazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18946-4
|
Metronidazole [Susceptibility] |
|
329-3
|
Metronidazole [Susceptibility] by Serum bactericidal titer |
|
41702-2
|
Mezlocillin [Susceptibility] by Gradient strip (E-test) |
|
332-7
|
Mezlocillin [Susceptibility] by Disk diffusion (KB) |
|
331-9
|
Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
330-1
|
Mezlocillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18947-2
|
Mezlocillin [Susceptibility] |
|
333-5
|
Mezlocillin [Susceptibility] by Serum bactericidal titer |
|
54196-1
|
Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54195-3
|
Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54194-6
|
Mezlocillin+Sulbactam [Susceptibility] |
|
53812-4
|
Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55686-0
|
Miconazole [Susceptibility] by Gradient strip (E-test) |
|
54180-5
|
Miconazole [Susceptibility] by Disk diffusion (KB) |
|
25722-0
|
Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25607-3
|
Miconazole [Susceptibility] |
|
25225-4
|
Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7032-6
|
Minocycline [Susceptibility] by Gradient strip (E-test) |
|
336-8
|
Minocycline [Susceptibility] by Disk diffusion (KB) |
|
335-0
|
Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
334-3
|
Minocycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
55156-4
|
Minocycline [Susceptibility] by Method for Slow-growing mycobacteria |
|
18948-0
|
Minocycline [Susceptibility] |
|
337-6
|
Minocycline [Susceptibility] by Serum bactericidal titer |
|
55687-8
|
Miocamycin [Susceptibility] by Gradient strip (E-test) |
|
340-0
|
Miocamycin [Susceptibility] by Disk diffusion (KB) |
|
339-2
|
Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
338-4
|
Miocamycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18949-8
|
Miocamycin [Susceptibility] |
|
341-8
|
Miocamycin [Susceptibility] by Serum bactericidal titer |
|
41703-0
|
Moxalactam [Susceptibility] by Gradient strip (E-test) |
|
344-2
|
Moxalactam [Susceptibility] by Disk diffusion (KB) |
|
343-4
|
Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
342-6
|
Moxalactam [Susceptibility] by Minimum lethal concentration (MLC) |
|
18950-6
|
Moxalactam [Susceptibility] |
|
345-9
|
Moxalactam [Susceptibility] by Serum bactericidal titer |
|
31043-3
|
Moxifloxacin [Susceptibility] by Gradient strip (E-test) |
|
31041-7
|
Moxifloxacin [Susceptibility] by Disk diffusion (KB) |
|
31037-5
|
Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41502-6
|
Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
31039-1
|
Moxifloxacin [Susceptibility] |
|
35492-8
|
Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] by Probe & target amplification method |
|
60543-6
|
Mupirocin 200 ug [Susceptibility] by Disk diffusion (KB) |
|
60542-8
|
Mupirocin 5 ug [Susceptibility] by Disk diffusion (KB) |
|
7033-4
|
Mupirocin [Susceptibility] by Gradient strip (E-test) |
|
35822-6
|
Mupirocin [Susceptibility] by Disk diffusion (KB) |
|
35823-4
|
Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
20389-3
|
Mupirocin [Susceptibility] |
|
29579-0
|
Mycobacterial susceptibility panel in Isolate |
|
41704-8
|
Nafcillin [Susceptibility] by Gradient strip (E-test) |
|
348-3
|
Nafcillin [Susceptibility] by Disk diffusion (KB) |
|
347-5
|
Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
346-7
|
Nafcillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18951-4
|
Nafcillin [Susceptibility] |
|
349-1
|
Nafcillin [Susceptibility] by Serum bactericidal titer |
|
7034-2
|
Nalidixate [Susceptibility] by Gradient strip (E-test) |
|
352-5
|
Nalidixate [Susceptibility] by Disk diffusion (KB) |
|
351-7
|
Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
350-9
|
Nalidixate [Susceptibility] by Minimum lethal concentration (MLC) |
|
18952-2
|
Nalidixate [Susceptibility] |
|
353-3
|
Nalidixate [Susceptibility] by Serum bactericidal titer |
|
32597-7
|
Natamycin [Susceptibility] |
|
30294-3
|
Nelfinavir [Susceptibility] by Genotype method |
|
30280-2
|
Nelfinavir [Susceptibility] by Phenotype method |
|
30309-9
|
Nelfinavir [Susceptibility] |
|
41705-5
|
Neomycin [Susceptibility] by Gradient strip (E-test) |
|
356-6
|
Neomycin [Susceptibility] by Disk diffusion (KB) |
|
355-8
|
Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
354-1
|
Neomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18953-0
|
Neomycin [Susceptibility] |
|
357-4
|
Neomycin [Susceptibility] by Serum bactericidal titer |
|
7035-9
|
Netilmicin [Susceptibility] by Gradient strip (E-test) |
|
360-8
|
Netilmicin [Susceptibility] by Disk diffusion (KB) |
|
359-0
|
Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
358-2
|
Netilmicin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18954-8
|
Netilmicin [Susceptibility] |
|
361-6
|
Netilmicin [Susceptibility] by Serum bactericidal titer |
|
30289-3
|
Nevirapine [Susceptibility] by Genotype method |
|
30275-2
|
Nevirapine [Susceptibility] by Phenotype method |
|
30311-5
|
Nevirapine [Susceptibility] |
|
7036-7
|
Nitrofurantoin [Susceptibility] by Gradient strip (E-test) |
|
364-0
|
Nitrofurantoin [Susceptibility] by Disk diffusion (KB) |
|
363-2
|
Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
362-4
|
Nitrofurantoin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18955-5
|
Nitrofurantoin [Susceptibility] |
|
365-7
|
Nitrofurantoin [Susceptibility] by Serum bactericidal titer |
|
55688-6
|
Nitroxoline [Susceptibility] by Gradient strip (E-test) |
|
54181-3
|
Nitroxoline [Susceptibility] by Disk diffusion (KB) |
|
25723-8
|
Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25608-1
|
Nitroxoline [Susceptibility] |
|
7037-5
|
Norfloxacin [Susceptibility] by Gradient strip (E-test) |
|
368-1
|
Norfloxacin [Susceptibility] by Disk diffusion (KB) |
|
367-3
|
Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
366-5
|
Norfloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
41504-2
|
Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18956-3
|
Norfloxacin [Susceptibility] |
|
369-9
|
Norfloxacin [Susceptibility] by Serum bactericidal titer |
|
41706-3
|
Novobiocin [Susceptibility] by Gradient strip (E-test) |
|
372-3
|
Novobiocin [Susceptibility] by Disk diffusion (KB) |
|
371-5
|
Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
370-7
|
Novobiocin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18957-1
|
Novobiocin [Susceptibility] |
|
373-1
|
Novobiocin [Susceptibility] by Serum bactericidal titer |
|
55689-4
|
Nystatin [Susceptibility] by Gradient strip (E-test) |
|
35824-2
|
Nystatin [Susceptibility] by Disk diffusion (KB) |
|
10697-1
|
Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
10698-9
|
Nystatin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18958-9
|
Nystatin [Susceptibility] |
|
41408-6
|
Ofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
41409-4
|
Ofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
41410-2
|
Ofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7038-3
|
Ofloxacin [Susceptibility] by Gradient strip (E-test) |
|
376-4
|
Ofloxacin [Susceptibility] by Disk diffusion (KB) |
|
375-6
|
Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
374-9
|
Ofloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20384-4
|
Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18959-7
|
Ofloxacin [Susceptibility] |
|
377-2
|
Ofloxacin [Susceptibility] by Serum bactericidal titer |
|
55690-2
|
Oleandomycin [Susceptibility] by Gradient strip (E-test) |
|
380-6
|
Oleandomycin [Susceptibility] by Disk diffusion (KB) |
|
379-8
|
Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
378-0
|
Oleandomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18960-5
|
Oleandomycin [Susceptibility] |
|
381-4
|
Oleandomycin [Susceptibility] by Serum bactericidal titer |
|
35825-9
|
Orbifloxacin [Susceptibility] by Disk diffusion (KB) |
|
35826-7
|
Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35827-5
|
Orbifloxacin [Susceptibility] |
|
41709-7
|
Oritavancin [Susceptibility] by Gradient strip (E-test) |
|
41707-1
|
Oritavancin [Susceptibility] by Disk diffusion (KB) |
|
41708-9
|
Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41736-0
|
Oritavancin [Susceptibility] |
|
55692-8
|
Ornidazole [Susceptibility] by Gradient strip (E-test) |
|
55693-6
|
Ornidazole [Susceptibility] by Disk diffusion (KB) |
|
55694-4
|
Ornidazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55691-0
|
Ornidazole [Susceptibility] |
|
60440-5
|
Oseltamivir [Susceptibility] by Genotype method |
|
60441-3
|
Oseltamivir+Zanamivir [Susceptibility] by Genotype method |
|
55617-5
|
Other Antibiotic [Susceptibility] by Gradient strip (E-test) |
|
45187-2
|
Other Antibiotic [Susceptibility] by Disk diffusion (KB) |
|
21070-8
|
Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
59833-4
|
Other Antibiotic [Susceptibility] by Minimum lethal concentration (MLC) |
|
15337-9
|
Other Antibiotic [Susceptibility] by Serum bactericidal titer --peak |
|
23658-8
|
Other Antibiotic [Susceptibility] |
|
15336-1
|
Other Antibiotic [Susceptibility] by Serum bactericidal titer |
|
15338-7
|
Other Antibiotic [Susceptibility] by Serum bactericidal titer --trough |
|
7039-1
|
Oxacillin [Susceptibility] by Gradient strip (E-test) |
|
384-8
|
Oxacillin [Susceptibility] by Disk diffusion (KB) |
|
383-0
|
Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
382-2
|
Oxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18961-3
|
Oxacillin [Susceptibility] |
|
385-5
|
Oxacillin [Susceptibility] by Serum bactericidal titer |
|
55698-5
|
Oxolinate [Susceptibility] by Gradient strip (E-test) |
|
55697-7
|
Oxolinate [Susceptibility] by Disk diffusion (KB) |
|
55695-1
|
Oxolinate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55696-9
|
Oxolinate [Susceptibility] |
|
55699-3
|
Oxytetracycline [Susceptibility] by Gradient strip (E-test) |
|
388-9
|
Oxytetracycline [Susceptibility] by Disk diffusion (KB) |
|
387-1
|
Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
386-3
|
Oxytetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18962-1
|
Oxytetracycline [Susceptibility] |
|
389-7
|
Oxytetracycline [Susceptibility] by Serum bactericidal titer |
|
53823-1
|
Panipenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55702-5
|
Paromomycin [Susceptibility] by Gradient strip (E-test) |
|
55701-7
|
Paromomycin [Susceptibility] by Disk diffusion (KB) |
|
53824-9
|
Paromomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
51719-3
|
Paromomycin [Susceptibility] |
|
48685-2
|
Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25215-5
|
Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25216-3
|
Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
54182-1
|
Para aminosalicylate [Susceptibility] by Disk diffusion (KB) |
|
14332-1
|
Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23611-7
|
Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria |
|
23629-9
|
Para aminosalicylate [Susceptibility] |
|
7040-9
|
Pefloxacin [Susceptibility] by Gradient strip (E-test) |
|
35828-3
|
Pefloxacin [Susceptibility] by Disk diffusion (KB) |
|
390-5
|
Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
18963-9
|
Pefloxacin [Susceptibility] |
|
51504-9
|
Penicillin G benzathine [Susceptibility] |
|
7041-7
|
Penicillin G [Susceptibility] by Gradient strip (E-test) |
|
393-9
|
Penicillin G [Susceptibility] by Disk diffusion (KB) |
|
392-1
|
Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
391-3
|
Penicillin G [Susceptibility] by Minimum lethal concentration (MLC) |
|
51503-1
|
Penicillin G procaine [Susceptibility] |
|
18965-4
|
Penicillin G [Susceptibility] |
|
394-7
|
Penicillin G [Susceptibility] by Serum bactericidal titer |
|
23925-1
|
Penicillin [Susceptibility] by Gradient strip (E-test) |
|
13968-3
|
Penicillin [Susceptibility] by Disk diffusion (KB) |
|
6932-8
|
Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55136-6
|
Penicillin Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
58085-2
|
Penicillin Parenteral [Susceptibility] |
|
55137-4
|
Penicillin Parenteral.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
58080-3
|
Penicillin Parenteral.meningitis [Susceptibility] |
|
18964-7
|
Penicillin [Susceptibility] |
|
7042-5
|
Penicillin V [Susceptibility] by Gradient strip (E-test) |
|
397-0
|
Penicillin V [Susceptibility] by Disk diffusion (KB) |
|
396-2
|
Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
395-4
|
Penicillin V [Susceptibility] by Minimum lethal concentration (MLC) |
|
18966-2
|
Penicillin V [Susceptibility] |
|
398-8
|
Penicillin V [Susceptibility] by Serum bactericidal titer |
|
35872-1
|
Penicillin+Novobiocin [Susceptibility] by Disk diffusion (KB) |
|
35873-9
|
Penicillin+Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35874-7
|
Penicillin+Novobiocin [Susceptibility] |
|
401-0
|
Phenethicillin [Susceptibility] by Disk diffusion (KB) |
|
400-2
|
Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
399-6
|
Phenethicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18967-0
|
Phenethicillin [Susceptibility] |
|
402-8
|
Phenethicillin [Susceptibility] by Serum bactericidal titer |
|
55703-3
|
Pipemidate [Susceptibility] by Gradient strip (E-test) |
|
405-1
|
Pipemidate [Susceptibility] by Disk diffusion (KB) |
|
404-4
|
Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
403-6
|
Pipemidate [Susceptibility] by Minimum lethal concentration (MLC) |
|
18968-8
|
Pipemidate [Susceptibility] |
|
406-9
|
Pipemidate [Susceptibility] by Serum bactericidal titer |
|
7043-3
|
Piperacillin [Susceptibility] by Gradient strip (E-test) |
|
409-3
|
Piperacillin [Susceptibility] by Disk diffusion (KB) |
|
408-5
|
Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
407-7
|
Piperacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18969-6
|
Piperacillin [Susceptibility] |
|
410-1
|
Piperacillin [Susceptibility] by Serum bactericidal titer |
|
55704-1
|
Piperacillin+Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
54199-5
|
Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
54198-7
|
Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54197-9
|
Piperacillin+Sulbactam [Susceptibility] |
|
7044-1
|
Piperacillin+Tazobactam [Susceptibility] by Gradient strip (E-test) |
|
413-5
|
Piperacillin+Tazobactam [Susceptibility] by Disk diffusion (KB) |
|
412-7
|
Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
411-9
|
Piperacillin+Tazobactam [Susceptibility] by Minimum lethal concentration (MLC) |
|
18970-4
|
Piperacillin+Tazobactam [Susceptibility] |
|
414-3
|
Piperacillin+Tazobactam [Susceptibility] by Serum bactericidal titer |
|
35829-1
|
Pirlimycin [Susceptibility] by Disk diffusion (KB) |
|
35830-9
|
Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35831-7
|
Pirlimycin [Susceptibility] |
|
55708-2
|
Piromidate [Susceptibility] by Gradient strip (E-test) |
|
55707-4
|
Piromidate [Susceptibility] by Disk diffusion (KB) |
|
55705-8
|
Piromidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55706-6
|
Piromidate [Susceptibility] |
|
417-6
|
Pivampicillin [Susceptibility] by Disk diffusion (KB) |
|
416-8
|
Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
415-0
|
Pivampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18971-2
|
Pivampicillin [Susceptibility] |
|
418-4
|
Pivampicillin [Susceptibility] by Serum bactericidal titer |
|
35832-5
|
Polymyxin B [Susceptibility] by Gradient strip (E-test) |
|
421-8
|
Polymyxin B [Susceptibility] by Disk diffusion (KB) |
|
420-0
|
Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
419-2
|
Polymyxin B [Susceptibility] by Minimum lethal concentration (MLC) |
|
18972-0
|
Polymyxin B [Susceptibility] |
|
422-6
|
Polymyxin B [Susceptibility] by Serum bactericidal titer |
|
54186-2
|
Posaconazole [Susceptibility] by Gradient strip (E-test) |
|
54189-6
|
Posaconazole [Susceptibility] by Disk diffusion (KB) |
|
54187-0
|
Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54188-8
|
Posaconazole [Susceptibility] |
|
55709-0
|
Pristinamycin [Susceptibility] by Gradient strip (E-test) |
|
35833-3
|
Pristinamycin [Susceptibility] by Disk diffusion (KB) |
|
35834-1
|
Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32383-2
|
Pristinamycin [Susceptibility] |
|
25229-6
|
Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55711-6
|
Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25186-8
|
Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
56026-8
|
Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55710-8
|
Pyrazinamide [Susceptibility] by Gradient strip (E-test) |
|
425-9
|
Pyrazinamide [Susceptibility] by Disk diffusion (KB) |
|
424-2
|
Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
423-4
|
Pyrazinamide [Susceptibility] by Minimum lethal concentration (MLC) |
|
20461-0
|
Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria |
|
18973-8
|
Pyrazinamide [Susceptibility] |
|
426-7
|
Pyrazinamide [Susceptibility] by Serum bactericidal titer |
|
33334-4
|
Quinupristin+Dalfopristin [Susceptibility] by Gradient strip (E-test) |
|
35835-8
|
Quinupristin+Dalfopristin [Susceptibility] by Disk diffusion (KB) |
|
23641-4
|
Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
58712-1
|
Quinupristin+Dalfopristin [Susceptibility] by Method for Slow-growing mycobacteria |
|
23640-6
|
Quinupristin+Dalfopristin [Susceptibility] |
|
61198-8
|
Raltegravir [Susceptibility] by Phenotype method |
|
41711-3
|
Ramoplanin [Susceptibility] by Gradient strip (E-test) |
|
41712-1
|
Ramoplanin [Susceptibility] by Disk diffusion (KB) |
|
41710-5
|
Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41737-8
|
Ramoplanin [Susceptibility] |
|
42655-1
|
Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25199-1
|
Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25200-7
|
Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25201-5
|
Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
54183-9
|
Rifabutin [Susceptibility] by Disk diffusion (KB) |
|
16100-0
|
Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
20386-9
|
Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria |
|
19149-4
|
Rifabutin [Susceptibility] |
|
16387-3
|
Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
25202-3
|
Rifampin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25184-3
|
Rifampin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25203-1
|
Rifampin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
55712-4
|
Rifampin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25204-9
|
Rifampin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7045-8
|
Rifampin [Susceptibility] by Gradient strip (E-test) |
|
429-1
|
Rifampin [Susceptibility] by Disk diffusion (KB) |
|
428-3
|
Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
427-5
|
Rifampin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20385-1
|
Rifampin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18974-6
|
Rifampin [Susceptibility] |
|
430-9
|
Rifampin [Susceptibility] by Serum bactericidal titer |
|
433-3
|
Ristocetin [Susceptibility] by Disk diffusion (KB) |
|
432-5
|
Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
431-7
|
Ristocetin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18975-3
|
Ristocetin [Susceptibility] |
|
434-1
|
Ristocetin [Susceptibility] by Serum bactericidal titer |
|
30293-5
|
Ritonavir [Susceptibility] by Genotype method |
|
30279-4
|
Ritonavir [Susceptibility] by Phenotype method |
|
30308-1
|
Ritonavir [Susceptibility] |
|
437-4
|
Rolitetracycline [Susceptibility] by Disk diffusion (KB) |
|
436-6
|
Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
435-8
|
Rolitetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
18976-1
|
Rolitetracycline [Susceptibility] |
|
438-2
|
Rolitetracycline [Susceptibility] by Serum bactericidal titer |
|
41714-7
|
Rosamicin [Susceptibility] by Gradient strip (E-test) |
|
41715-4
|
Rosamicin [Susceptibility] by Disk diffusion (KB) |
|
41713-9
|
Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41738-6
|
Rosamicin [Susceptibility] |
|
55713-2
|
Rosoxacin [Susceptibility] by Gradient strip (E-test) |
|
441-6
|
Rosoxacin [Susceptibility] by Disk diffusion (KB) |
|
440-8
|
Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
439-0
|
Rosoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18977-9
|
Rosoxacin [Susceptibility] |
|
442-4
|
Rosoxacin [Susceptibility] by Serum bactericidal titer |
|
7046-6
|
Roxithromycin [Susceptibility] by Gradient strip (E-test) |
|
445-7
|
Roxithromycin [Susceptibility] by Disk diffusion (KB) |
|
444-0
|
Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
443-2
|
Roxithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18978-7
|
Roxithromycin [Susceptibility] |
|
446-5
|
Roxithromycin [Susceptibility] by Serum bactericidal titer |
|
35836-6
|
Salinomycin [Susceptibility] by Disk diffusion (KB) |
|
35837-4
|
Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35838-2
|
Salinomycin [Susceptibility] |
|
30295-0
|
Saquinavir [Susceptibility] by Genotype method |
|
30281-0
|
Saquinavir [Susceptibility] by Phenotype method |
|
30310-7
|
Saquinavir [Susceptibility] |
|
49621-6
|
Saquinavir+Ritonavir [Susceptibility] by Genotype method |
|
58024-1
|
Saquinavir+Ritonavir [Susceptibility] by Phenotype method |
|
20390-1
|
Silvadine.topical [Susceptibility] |
|
55714-0
|
Sisomicin [Susceptibility] by Gradient strip (E-test) |
|
449-9
|
Sisomicin [Susceptibility] by Disk diffusion (KB) |
|
448-1
|
Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
447-3
|
Sisomicin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18979-5
|
Sisomicin [Susceptibility] |
|
450-7
|
Sisomicin [Susceptibility] by Serum bactericidal titer |
|
7047-4
|
Sparfloxacin [Susceptibility] by Gradient strip (E-test) |
|
35839-0
|
Sparfloxacin [Susceptibility] by Disk diffusion (KB) |
|
20397-6
|
Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23610-9
|
Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
|
23628-1
|
Sparfloxacin [Susceptibility] |
|
35840-8
|
Spectinomycin [Susceptibility] by Gradient strip (E-test) |
|
453-1
|
Spectinomycin [Susceptibility] by Disk diffusion (KB) |
|
452-3
|
Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
451-5
|
Spectinomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18980-3
|
Spectinomycin [Susceptibility] |
|
454-9
|
Spectinomycin [Susceptibility] by Serum bactericidal titer |
|
55715-7
|
Spiramycin [Susceptibility] by Gradient strip (E-test) |
|
457-2
|
Spiramycin [Susceptibility] by Disk diffusion (KB) |
|
456-4
|
Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
455-6
|
Spiramycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18981-1
|
Spiramycin [Susceptibility] |
|
458-0
|
Spiramycin [Susceptibility] by Serum bactericidal titer |
|
30286-9
|
Stavudine [Susceptibility] by Genotype method |
|
30272-9
|
Stavudine [Susceptibility] by Phenotype method |
|
30302-4
|
Stavudine [Susceptibility] |
|
48177-0
|
Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25206-4
|
Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25205-6
|
Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
46719-1
|
Streptomycin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
25185-0
|
Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
35841-6
|
Streptomycin.high potency [Susceptibility] by Gradient strip (E-test) |
|
7049-0
|
Streptomycin.high potency [Susceptibility] by Disk diffusion (KB) |
|
6933-6
|
Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
18983-7
|
Streptomycin.high potency [Susceptibility] |
|
7048-2
|
Streptomycin [Susceptibility] by Gradient strip (E-test) |
|
461-4
|
Streptomycin [Susceptibility] by Disk diffusion (KB) |
|
460-6
|
Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
459-8
|
Streptomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
20462-8
|
Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18982-9
|
Streptomycin [Susceptibility] |
|
462-2
|
Streptomycin [Susceptibility] by Serum bactericidal titer |
|
41717-0
|
Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
41716-2
|
Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
41718-8
|
Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41739-4
|
Sulbactam [Susceptibility] |
|
7050-8
|
Sulfadiazine [Susceptibility] by Gradient strip (E-test) |
|
465-5
|
Sulfadiazine [Susceptibility] by Disk diffusion (KB) |
|
464-8
|
Sulfadiazine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
463-0
|
Sulfadiazine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18984-5
|
Sulfadiazine [Susceptibility] |
|
466-3
|
Sulfadiazine [Susceptibility] by Serum bactericidal titer |
|
11577-4
|
Sulfamethoxazole [Susceptibility] by Gradient strip (E-test) |
|
469-7
|
Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) |
|
468-9
|
Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
467-1
|
Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18985-2
|
Sulfamethoxazole [Susceptibility] |
|
470-5
|
Sulfamethoxazole [Susceptibility] by Serum bactericidal titer |
|
25226-2
|
Sulfisoxazole 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
11578-2
|
Sulfisoxazole [Susceptibility] by Gradient strip (E-test) |
|
473-9
|
Sulfisoxazole [Susceptibility] by Disk diffusion (KB) |
|
472-1
|
Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
471-3
|
Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
18986-0
|
Sulfisoxazole [Susceptibility] |
|
474-7
|
Sulfisoxazole [Susceptibility] by Serum bactericidal titer |
|
35842-4
|
Sulfonamide [Susceptibility] by Gradient strip (E-test) |
|
477-0
|
Sulfonamide [Susceptibility] by Disk diffusion (KB) |
|
476-2
|
Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
475-4
|
Sulfonamide [Susceptibility] by Minimum lethal concentration (MLC) |
|
18987-8
|
Sulfonamide [Susceptibility] |
|
478-8
|
Sulfonamide [Susceptibility] by Serum bactericidal titer |
|
55291-9
|
Sulopenem [Susceptibility] by Disk diffusion (KB) |
|
55290-1
|
Sulopenem [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55289-3
|
Sulopenem [Susceptibility] |
|
19156-9
|
Susceptibility method [Identifier] in Unspecified specimen |
|
481-2
|
Talampicillin [Susceptibility] by Disk diffusion (KB) |
|
480-4
|
Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
479-6
|
Talampicillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18988-6
|
Talampicillin [Susceptibility] |
|
482-0
|
Talampicillin [Susceptibility] by Serum bactericidal titer |
|
41720-4
|
Tazobactam [Susceptibility] by Gradient strip (E-test) |
|
41719-6
|
Tazobactam [Susceptibility] by Disk diffusion (KB) |
|
41721-2
|
Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41740-2
|
Tazobactam [Susceptibility] |
|
7051-6
|
Teicoplanin [Susceptibility] by Gradient strip (E-test) |
|
485-3
|
Teicoplanin [Susceptibility] by Disk diffusion (KB) |
|
484-6
|
Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
483-8
|
Teicoplanin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18989-4
|
Teicoplanin [Susceptibility] |
|
486-1
|
Teicoplanin [Susceptibility] by Serum bactericidal titer |
|
56792-5
|
Telbivudine [Susceptibility] by Genotype method |
|
41722-0
|
Telithromycin [Susceptibility] by Gradient strip (E-test) |
|
35843-2
|
Telithromycin [Susceptibility] by Disk diffusion (KB) |
|
35844-0
|
Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35845-7
|
Telithromycin [Susceptibility] |
|
489-5
|
Temafloxacin [Susceptibility] by Disk diffusion (KB) |
|
488-7
|
Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
487-9
|
Temafloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18990-2
|
Temafloxacin [Susceptibility] |
|
490-3
|
Temafloxacin [Susceptibility] by Serum bactericidal titer |
|
54190-4
|
Temocillin [Susceptibility] by Gradient strip (E-test) |
|
493-7
|
Temocillin [Susceptibility] by Disk diffusion (KB) |
|
492-9
|
Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
491-1
|
Temocillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18991-0
|
Temocillin [Susceptibility] |
|
494-5
|
Temocillin [Susceptibility] by Serum bactericidal titer |
|
41396-3
|
Tenofovir [Susceptibility] by Genotype method |
|
34644-5
|
Tenofovir [Susceptibility] by Phenotype method |
|
33627-1
|
Tenofovir [Susceptibility] |
|
10720-1
|
Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
10721-9
|
Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) |
|
18992-8
|
Terbinafine [Susceptibility] |
|
55196-0
|
Terconazole [Susceptibility] |
|
7052-4
|
Tetracycline [Susceptibility] by Gradient strip (E-test) |
|
497-8
|
Tetracycline [Susceptibility] by Disk diffusion (KB) |
|
496-0
|
Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
495-2
|
Tetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
|
62260-5
|
Tetracycline resistance gene [Presence] by Probe & target amplification method |
|
18993-6
|
Tetracycline [Susceptibility] |
|
498-6
|
Tetracycline [Susceptibility] by Serum bactericidal titer |
|
54184-7
|
Thiacetazone [Susceptibility] by Disk diffusion (KB) |
|
54204-3
|
Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
32384-0
|
Thiacetazone [Susceptibility] |
|
41724-6
|
Thiamphenicol [Susceptibility] by Gradient strip (E-test) |
|
41723-8
|
Thiamphenicol [Susceptibility] by Disk diffusion (KB) |
|
41725-3
|
Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54169-8
|
Thiamphenicol [Susceptibility] |
|
35846-5
|
Tiamulin [Susceptibility] by Disk diffusion (KB) |
|
35847-3
|
Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35848-1
|
Tiamulin [Susceptibility] |
|
7053-2
|
Ticarcillin [Susceptibility] by Gradient strip (E-test) |
|
501-7
|
Ticarcillin [Susceptibility] by Disk diffusion (KB) |
|
500-9
|
Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
499-4
|
Ticarcillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18994-4
|
Ticarcillin [Susceptibility] |
|
502-5
|
Ticarcillin [Susceptibility] by Serum bactericidal titer |
|
7054-0
|
Ticarcillin+Clavulanate [Susceptibility] by Gradient strip (E-test) |
|
505-8
|
Ticarcillin+Clavulanate [Susceptibility] by Disk diffusion (KB) |
|
504-1
|
Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
503-3
|
Ticarcillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) |
|
18995-1
|
Ticarcillin+Clavulanate [Susceptibility] |
|
506-6
|
Ticarcillin+Clavulanate [Susceptibility] by Serum bactericidal titer |
|
55719-9
|
Ticarcillin+Sulbactam [Susceptibility] by Gradient strip (E-test) |
|
55718-1
|
Ticarcillin+Sulbactam [Susceptibility] by Disk diffusion (KB) |
|
55716-5
|
Ticarcillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55717-3
|
Ticarcillin+Sulbactam [Susceptibility] |
|
42354-1
|
Tigecycline [Susceptibility] by Gradient strip (E-test) |
|
42356-6
|
Tigecycline [Susceptibility] by Disk diffusion (KB) |
|
42355-8
|
Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
55158-0
|
Tigecycline [Susceptibility] by Method for Slow-growing mycobacteria |
|
42357-4
|
Tigecycline [Susceptibility] |
|
35849-9
|
Tilmicosin [Susceptibility] by Disk diffusion (KB) |
|
35850-7
|
Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35851-5
|
Tilmicosin [Susceptibility] |
|
55722-3
|
Tinidazole [Susceptibility] by Gradient strip (E-test) |
|
55721-5
|
Tinidazole [Susceptibility] by Disk diffusion (KB) |
|
55720-7
|
Tinidazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
54928-7
|
Tinidazole [Susceptibility] |
|
43737-6
|
Tipranavir [Susceptibility] by Genotype method |
|
49667-9
|
Tipranavir [Susceptibility] by Phenotype method |
|
42535-5
|
Tipranavir [Susceptibility] |
|
49622-4
|
Tipranavir+Ritonavir [Susceptibility] by Genotype method |
|
58029-0
|
Tipranavir+Ritonavir [Susceptibility] by Phenotype method |
|
7057-3
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Gradient strip (E-test) |
|
517-3
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) |
|
516-5
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
515-7
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
20387-7
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria |
|
18998-5
|
Trimethoprim+Sulfamethoxazole [Susceptibility] |
|
518-1
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Serum bactericidal titer |
|
25227-0
|
Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7055-7
|
Tobramycin [Susceptibility] by Gradient strip (E-test) |
|
509-0
|
Tobramycin [Susceptibility] by Disk diffusion (KB) |
|
508-2
|
Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
507-4
|
Tobramycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
25800-4
|
Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
18996-9
|
Tobramycin [Susceptibility] |
|
510-8
|
Tobramycin [Susceptibility] by Serum bactericidal titer |
|
7056-5
|
Trimethoprim [Susceptibility] by Gradient strip (E-test) |
|
513-2
|
Trimethoprim [Susceptibility] by Disk diffusion (KB) |
|
512-4
|
Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
511-6
|
Trimethoprim [Susceptibility] by Minimum lethal concentration (MLC) |
|
23614-1
|
Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria |
|
18997-7
|
Trimethoprim [Susceptibility] |
|
514-0
|
Trimethoprim [Susceptibility] by Serum bactericidal titer |
|
521-5
|
Troleandomycin [Susceptibility] by Disk diffusion (KB) |
|
520-7
|
Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
519-9
|
Troleandomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
18999-3
|
Troleandomycin [Susceptibility] |
|
522-3
|
Troleandomycin [Susceptibility] by Serum bactericidal titer |
|
35852-3
|
Trospectinomycin [Susceptibility] by Disk diffusion (KB) |
|
35853-1
|
Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35854-9
|
Trospectinomycin [Susceptibility] |
|
7058-1
|
Trovafloxacin [Susceptibility] by Gradient strip (E-test) |
|
35855-6
|
Trovafloxacin [Susceptibility] by Disk diffusion (KB) |
|
23643-0
|
Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
23642-2
|
Trovafloxacin [Susceptibility] |
|
35856-4
|
Tylosin [Susceptibility] by Disk diffusion (KB) |
|
35857-2
|
Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35858-0
|
Tylosin [Susceptibility] |
|
48814-8
|
vanA gene [Presence] by Probe & target amplification method |
|
25228-8
|
Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
|
7059-9
|
Vancomycin [Susceptibility] by Gradient strip (E-test) |
|
525-6
|
Vancomycin [Susceptibility] by Disk diffusion (KB) |
|
524-9
|
Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
523-1
|
Vancomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23615-8
|
Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
62261-3
|
Vancomycin resistance gene [Presence] by Probe & target amplification method |
|
19000-9
|
Vancomycin [Susceptibility] |
|
526-4
|
Vancomycin [Susceptibility] by Serum bactericidal titer |
|
529-8
|
Viomycin [Susceptibility] by Disk diffusion (KB) |
|
528-0
|
Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
527-2
|
Viomycin [Susceptibility] by Minimum lethal concentration (MLC) |
|
23616-6
|
Viomycin [Susceptibility] by Method for Slow-growing mycobacteria |
|
19001-7
|
Viomycin [Susceptibility] |
|
530-6
|
Viomycin [Susceptibility] by Serum bactericidal titer |
|
29578-2
|
Viral susceptibility panel in Isolate |
|
55723-1
|
Virginiamycin [Susceptibility] by Gradient strip (E-test) |
|
35859-8
|
Virginiamycin [Susceptibility] by Disk diffusion (KB) |
|
35860-6
|
Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
35861-4
|
Virginiamycin [Susceptibility] |
|
35862-2
|
Voriconazole [Susceptibility] by Gradient strip (E-test) |
|
41200-7
|
Voriconazole [Susceptibility] by Disk diffusion (KB) |
|
35863-0
|
Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
41199-1
|
Voriconazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
32379-0
|
Voriconazole [Susceptibility] |
|
30285-1
|
Zalcitabine [Susceptibility] by Genotype method |
|
30271-1
|
Zalcitabine [Susceptibility] by Phenotype method |
|
30301-6
|
Zalcitabine [Susceptibility] |
|
30282-8
|
Zidovudine [Susceptibility] by Genotype method |
|
30268-7
|
Zidovudine [Susceptibility] by Phenotype method |
|
531-4
|
Zidovudine [Susceptibility] |